CIT · Cit Group Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $634.80M | $687.40M | $810.50M | - | $541.80M | $324.30M | $114.40M | - | $545.60M | $563.30M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | $310.80M | $267.80M |
| D&A | - | - | $84.70M | - | - | - | $78.30M | - | - | - |
| Operating Income | $231.00M | $298.60M | $400.10M | - | $115.20M | ($158.50M) | ($696.60M) | - | $116.80M | $170.20M |
| Interest Expense | $103.00M | $106.80M | $119.60M | - | $165.50M | $202.50M | $225.70M | - | $243.90M | $242.70M |
| Income Tax | $55.50M | $71.70M | $96.30M | - | $29.50M | ($73.20M) | ($72.30M) | - | ($26.00M) | $33.40M |
| Net Income | $175.50M | $226.90M | $303.80M | - | $85.70M | ($85.30M) | ($624.30M) | - | $142.80M | $137.60M |
| EPS - Basic | $1.74 | $2.17 | $3.05 | - | $0.84 | ($0.99) | ($6.40) | - | $1.51 | $1.33 |
| EPS - Diluted | $1.72 | $2.14 | $3.04 | - | $0.84 | ($0.99) | ($6.40) | - | $1.50 | $1.33 |
Balance Sheet
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | - | - | - | - | - | - | - | - | - |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $54.42B | $54.70B | $56.05B | $58.11B | $60.87B | $61.70B | $58.94B | $50.83B | $51.40B | $50.56B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | $4.25B | $4.24B | $4.84B | $5.84B | $7.28B | $7.60B | $8.09B | $6.47B | $6.42B | $6.33B |
| Total Liabilities | $48.25B | $48.67B | $50.23B | $52.38B | $55.10B | $55.96B | $53.08B | $44.49B | $45.37B | $44.64B |
| Stockholders' Equity | $6.17B | $6.04B | $5.82B | $5.72B | $5.76B | $5.74B | $5.86B | $6.34B | $6.32B | $6.53B |
| Retained Earnings | $2.01B | $1.87B | $1.69B | $1.43B | $1.47B | $1.42B | $1.55B | $2.31B | $2.22B | $2.11B |
Cash Flow
| Line item | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $274.10M | - | - | - | ($344.50M) | - | - | - |
| Investing Cash Flow | - | - | $3.15B | - | - | - | $251.00M | - | - | - |
| Financing Cash Flow | - | - | ($2.09B) | - | - | - | $1.11B | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 | Q4 '19 | Q3 '19 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 36.4% | 43.4% | 49.4% | - | 21.3% | -48.9% | -608.9% | - | 21.4% | 30.2% |
| EBITDA margin | - | - | 59.8% | - | - | - | -540.5% | - | - | - |
| Net margin | 27.6% | 33.0% | 37.5% | - | 15.8% | -26.3% | -545.7% | - | 26.2% | 24.4% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 24.0% | 24.0% | 24.1% | - | 25.6% | - | - | - | -22.3% | 19.5% |
| Return on assets | 0.3% | 0.4% | 0.5% | - | 0.1% | -0.1% | -1.1% | - | 0.3% | 0.3% |
| Return on equity | 2.8% | 3.8% | 5.2% | - | 1.5% | -1.5% | -10.7% | - | 2.3% | 2.1% |
| Return on invested capital | 1.7% | 2.2% | 2.9% | - | 0.7% | -0.9% | -3.9% | - | 0.9% | 1.1% |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | 0.69 | 0.70 | 0.83 | 1.02 | 1.26 | 1.32 | 1.38 | 1.02 | 1.02 | 0.97 |
| Debt / Assets | 0.08 | 0.08 | 0.09 | 0.10 | 0.12 | 0.12 | 0.14 | 0.13 | 0.12 | 0.13 |
| Debt / EBITDA | - | - | 9.98 | - | - | - | - | - | - | - |
| Interest coverage | 2.2x | 2.8x | 3.3x | - | 0.7x | -0.8x | -3.1x | - | 0.5x | 0.7x |
| Equity multiplier | 8.81 | 9.06 | 9.64 | 10.15 | 10.56 | 10.75 | 10.06 | 8.02 | 8.13 | 7.75 |
| Liabilities / Assets | 0.89 | 0.89 | 0.90 | 0.90 | 0.91 | 0.91 | 0.90 | 0.88 | 0.88 | 0.88 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.00 | - | 0.01 | 0.01 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 17.2% | 112.0% | 608.5% | - | -0.7% | -42.4% | -79.7% | - | -4.6% | -10.9% |
| Revenue CAGR (3y) | 3.5% | 2.8% | 13.1% | - | -1.3% | -18.6% | -41.6% | - | -12.1% | -13.1% |
| Revenue CAGR (5y) | -4.6% | -4.3% | 0.6% | - | -4.6% | -11.4% | -28.0% | - | -0.3% | -2.8% |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 100.5% | - | - | - | -1.4% | - | - | - | -31.6% | -16.9% |
| Net income growth (YoY) | 104.8% | - | - | - | -40.0% | - | - | - | 8.6% | 8.5% |
| EPS growth (YoY) | 104.8% | - | - | - | -44.0% | - | - | - | 30.4% | 41.5% |
| EPS CAGR (3y) | 14.4% | 31.6% | 60.2% | - | -19.5% | - | - | - | 32.1% | 166.8% |
| EPS CAGR (5y) | 21.5% | 98.2% | 33.0% | - | -25.3% | - | - | - | -11.5% | 0.6% |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 7.1% | 5.2% | -0.8% | -9.7% | -8.8% | -12.1% | -19.9% | 6.6% | 0.0% | 0.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2020-12-31.
Geographic
$3.15B totalUS$3.06B · 97.2%
Non Us$87.50M · 2.8%
Peer comparison
Same SIC group: National Commercial Banks
Comparing CIT GROUP INC against the 5 most active filers in the same SIC group.